申请人:Sugen. Inc.
公开号:US20030100555A1
公开(公告)日:2003-05-29
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
本发明涉及吡咯替代的2-吲哚酮化合物及其药学上可接受的盐,这些化合物调节蛋白激酶的活性,因此预计在预防和治疗蛋白激酶相关的细胞疾病,如癌症方面具有用处。